Authors: BACRACHEVA N TYUTYULKOVA N DRENSKA A GORANTCHEVA J SCHINZEL S SCHOLL T STOINOV A TCHAKARSKI I TENTCHEVA J VLAHOV V

Citation: N. Bacracheva et al., EFFECT OF CIMETIDINE ON THE PHARMACOKINETICS OF THE METABOLITES OF METAMIZOL, International journal of clinical pharmacology and therapeutics, 35(7), 1997, pp. 275-281

Authors: VLAHOV V BACRACHEVA N TONTCHEVA D NAUMOVA E MAVRUDIEVA M ILIEVA P MICHAILOVA A

Citation: V. Vlahov et al., GENETIC-FACTORS AND RISK OF AGRANULOCYTOSIS FROM METAMIZOL, Pharmacogenetics, 6(1), 1996, pp. 67-72

Authors: BACRACHEVA N KAMALI F

Citation: N. Bacracheva et F. Kamali, LACK OF INTERACTION BETWEEN ZIDOVUDINE AND 4-METHYL-AMINO-ANTIPYRINE,THE ACTIVE METABOLITE OF METAMIZOLE, IN HUMAN LIVER IN-VITRO, Methods and findings in experimental and clinical pharmacology, 17(5), 1995, pp. 299-301

Authors: BACRACHEVA N VLAHOV V

Citation: N. Bacracheva et V. Vlahov, THE ACETYLATION PHENOTYPE - DOES IT CONTRIBUTE TO THE NONLINEARITY OFTHE METABOLITE PHARMACOKINETICS OF METAMIZOL, European Journal of Clinical Pharmacology, 48(1), 1995, pp. 79-80

Authors: BACRACHEVA N DRENSKA A GORANTCHEVA J TYUTYULKOVA N VLAHOV V

Citation: N. Bacracheva et al., COMPARATIVE BIOAVAILABILITY OF 2 ORAL METAMIZOLE FORMULATIONS - INFLUENCE OF THE ACETYLATION PHENOTYPE, Arzneimittel-Forschung, 45-1(3), 1995, pp. 282-285